Literature DB >> 19602589

The G protein-coupled receptor 87 is necessary for p53-dependent cell survival in response to genotoxic stress.

Yanhong Zhang1, Yingjuan Qian, Wenfu Lu, Xinbin Chen.   

Abstract

p53 regulates an array of target genes, which mediates p53 tumor suppression by inducing cell cycle arrest, apoptosis, and cell survival. G protein-coupled receptors belong to a superfamily of cell surface molecules and are known to regulate cell proliferation, migration, and survival. Here, we found that G protein-coupled receptor 87 (GPR87) was up-regulated by p53 and by DNA damage in a p53-dependent manner. We also found that p53 directly regulated GPR87 potentially via a p53-responsive element in the GPR87 gene. To investigate the role of GPR87 in the p53 pathway, we generated multiple RKO and MCF7 cell lines in that GPR87 can be inducibly overexpressed or knocked down by a tetracycline-inducible system. We found that overexpression of GPR87 had little effect on cell growth. However, GPR87 knockdown sensitized cancer cells to DNA damage-induced growth suppression via enhanced p53 stabilization and activation. Importantly, the prosurvival activity of GPR87 can be reversed by knockdown of p53. Together, our results suggested that GPR87 is essential for p53-dependent cell survival in response to DNA damage. Thus, due to its expression on the cell surface and its role in cell survival, GPR87 may be explored as a novel therapeutic target for cancer treatment and prevention.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19602589      PMCID: PMC2719689          DOI: 10.1158/0008-5472.CAN-09-0621

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

Review 1.  Inherited diseases involving g proteins and g protein-coupled receptors.

Authors:  Allen M Spiegel; Lee S Weinstein
Journal:  Annu Rev Med       Date:  2004       Impact factor: 13.739

Review 2.  The p53 pathway: positive and negative feedback loops.

Authors:  Sandra L Harris; Arnold J Levine
Journal:  Oncogene       Date:  2005-04-18       Impact factor: 9.867

3.  DNA polymerase eta, the product of the xeroderma pigmentosum variant gene and a target of p53, modulates the DNA damage checkpoint and p53 activation.

Authors:  Gang Liu; Xinbin Chen
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

4.  The C terminus of p53 family proteins is a cell fate determinant.

Authors:  Kelly Lynn Harms; Xinbin Chen
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

5.  Requirement for p53 and p21 to sustain G2 arrest after DNA damage.

Authors:  F Bunz; A Dutriaux; C Lengauer; T Waldman; S Zhou; J P Brown; J M Sedivy; K W Kinzler; B Vogelstein
Journal:  Science       Date:  1998-11-20       Impact factor: 47.728

Review 6.  p53: puzzle and paradigm.

Authors:  L J Ko; C Prives
Journal:  Genes Dev       Date:  1996-05-01       Impact factor: 11.361

7.  PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells.

Authors:  Adrienne Boire; Lidija Covic; Anika Agarwal; Suzanne Jacques; Sheida Sherifi; Athan Kuliopulos
Journal:  Cell       Date:  2005-02-11       Impact factor: 41.582

8.  Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer.

Authors:  C Carmeci; D A Thompson; H Z Ring; U Francke; R J Weigel
Journal:  Genomics       Date:  1997-11-01       Impact factor: 5.736

Review 9.  The common and distinct target genes of the p53 family transcription factors.

Authors:  K Harms; S Nozell; X Chen
Journal:  Cell Mol Life Sci       Date:  2004-04       Impact factor: 9.261

10.  p53, through p21 (WAF1/CIP1), induces cyclin D1 synthesis.

Authors:  X Chen; J Bargonetti; C Prives
Journal:  Cancer Res       Date:  1995-10-01       Impact factor: 12.701

View more
  28 in total

Review 1.  G protein-coupled receptors: novel targets for drug discovery in cancer.

Authors:  Rosamaria Lappano; Marcello Maggiolini
Journal:  Nat Rev Drug Discov       Date:  2011-01       Impact factor: 84.694

Review 2.  GPCRs and cancer.

Authors:  Rosamaria Lappano; Marcello Maggiolini
Journal:  Acta Pharmacol Sin       Date:  2012-01-23       Impact factor: 6.150

3.  Serine/threonine kinase 17A is a novel p53 target gene and modulator of cisplatin toxicity and reactive oxygen species in testicular cancer cells.

Authors:  Pingping Mao; Mary P Hever; Lynne M Niemaszyk; Jessica M Haghkerdar; Esty G Yanco; Damayanti Desai; Maroun J Beyrouthy; Joanna S Kerley-Hamilton; Sarah J Freemantle; Michael J Spinella
Journal:  J Biol Chem       Date:  2011-04-13       Impact factor: 5.157

4.  G Protein-Coupled Receptor 87: a Promising Opportunity for Cancer Drug Discovery.

Authors:  Yanhong Zhang; Ariane Scoumanne; Xinbin Chen
Journal:  Mol Cell Pharmacol       Date:  2010-01-01

Review 5.  Aiming drug discovery at lysophosphatidic acid targets.

Authors:  Gabor Tigyi
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

Review 6.  Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials.

Authors:  Bruna Scaggiante; Maryam Kazemi; Gabriele Pozzato; Barbara Dapas; Rosella Farra; Mario Grassi; Fabrizio Zanconati; Gabriele Grassi
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

7.  Tumor protein translationally controlled 1 is a p53 target gene that promotes cell survival.

Authors:  Weimin Chen; Huihui Wang; Shasha Tao; Yi Zheng; Wei Wu; Fangru Lian; Melba Jaramillo; Deyu Fang; Donna D Zhang
Journal:  Cell Cycle       Date:  2013-07-15       Impact factor: 4.534

Review 8.  Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer.

Authors:  M T M van Jaarsveld; J M Houthuijzen; E E Voest
Journal:  Oncogene       Date:  2015-12-07       Impact factor: 9.867

Review 9.  Pancreatic Adenocarcinoma: Unconventional Approaches for an Unconventional Disease.

Authors:  Christopher Gromisch; Motaz Qadan; Mariana Albuquerque Machado; Kebin Liu; Yolonda Colson; Mark W Grinstaff
Journal:  Cancer Res       Date:  2020-03-27       Impact factor: 12.701

10.  Overexpression of G protein-coupled receptor 87 correlates with poorer tumor differentiation and higher tumor proliferation in non-small-cell lung cancer.

Authors:  Kazuhito Nii; Yoshimasa Tokunaga; Dage Liu; Xia Zhang; Jun Nakano; Shinya Ishikawa; Yoshiyuki Kakehi; Reiji Haba; Hiroyasu Yokomise
Journal:  Mol Clin Oncol       Date:  2014-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.